![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Clinical Trials
Cmed to Demonstrate how encapsia® Transforms Clinical Trial Data Management, Capture and Reporting at Leading Oncology Meetings
Cmed, an oncology focused, innovative technology-led CRO, announced that it will showcase its encapsia® clinical data suite at two leading oncology meetings, Clinical Operations...
Articles
Direct-to-Patient Solutions Assuring Patient Participation and Retention in Clinical Trials
The average cost of bringing a new drug to market is $2.6 billion, according to a 2014 report published by Tufts Center for the...
Clinical Trials
Cmed to Showcase Advanced Data Insights and Analytics Capabilities of encapsia® Clinical Data Suite at Partnerships in Clinical Trials Europe
Cmed, an innovative technology-led CRO, will demonstrate its encapsia® clinical data suite at Partnerships in Clinical Trials Europe, taking place 28-29 November 2017 in...
Articles
Asia’s increasing levels of clinical trial industry competition are to your benefit
Biotechnology and pharmaceutical companies within the United States and Europe face an increasing number of hurdles when undertaking clinical trials within their own country or region; problems such as...
Articles
New centre is tackling manufacturing challenge of cell therapy field
Stem cell science has made huge progress since the early 1960s when Canadian researchers James Till and Ernest McCulloch discovered blood stem cells and...
Clinical Trials
Chi-Med Reports Preliminary Phase II data on Fruquintinib Combination in First-Line Lung Cancer
Hutchison China MediTech Limited reported preliminary clinical activity, safety, and tolerability data of fruquintinib, an investigational selective inhibitor of vascular endothelial growth factor receptor...
Clinical Trials
MC2 Therapeutics A/S Announces First Patient Dosed in Pivotal US Phase 3 Trial in Psoriasis Vulgaris
MC2 Therapeutics A/S, a clinical-stage dermatology and eye care company today announced that first patient has been dosed in its pivotal Phase 3 clinical...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read